Carregant...

Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature

RATIONALE: Ticagrelor, a new type of P2Y(12) receptor antagonist, has been highly recommended to be used in acute coronary syndrome by the latest guideline, but its side effects are not well-known. We seek to illustrate a potential fatal condition, thrombotic thrombocytopenic purpura (TTP), caused b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Wang, Xiaoya, Zhang, Shufang, Li, Leiqing, Hua, Junjie, Zhu, Lei, Li, Libin, Zhang, Gensheng
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039671/
https://ncbi.nlm.nih.gov/pubmed/29952973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011206
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!